Portfolio

Investment date: July 2000

Commitment: DKK 377m

Fund size: DKK 2,390m

Ownership share: 15.8 %

Advisory board member: Nils Johannessen

Investment strategy: Axcel focuses on diversified investment activities in opportunity-focused medium-sized Danish and Southern Swedish companies in relation to business succession, delisting and expansion. The fund is headquartered in Copenhagen.

Investment date: July 2000

Commitment: DKK 377m

Fund size: DKK 2,390m

Ownership share: 15.8 %

Advisory board member: Nils Johannessen

Investment strategy: Axcel focuses on diversified investment activities in opportunity-focused medium-sized Danish and Southern Swedish companies in relation to business succession, delisting and expansion. The fund is headquartered in Copenhagen.

Investment date: May 1984

Commitment: DKK 81m

Fund size: DKK 2,390m

Ownership share: 15.8 %

Advisory board member: No

Investment strategy: Dansk Erhvervsinvestering is a Danish firm investing in production, telco and healthcare/biotechnology sectors. The firm is based in Copenhagen.

Investment date: December 2011

Commitment:  DKK 213.5m

Fund size: DKK 4,088m

Ownership share: 5.2 %

Advisory board member: Nils Johannessen

Investment strategy: Dansk Vækstkapital invests in unlisted funds with a view to achieving a competitive and double-digit return for the combined portfolio of funds. The funds need to be of a size – and have critical mass – that makes them commercially viable, building upon the existing skills of established fund managers who possess specialist knowledge. Therefore, the required minimum fund size is usually DKK 400-500 million (EUR 54-70 million).

Investment date: December 2011

Commitment:  DKK 640.5m

Fund size: DKK 4,088m

Ownership share: 15.7 %

Advisory board member: No

Investment strategy: Dansk Vækstkapital invests in unlisted funds with a view to achieving a competitive and double-digit return for the combined portfolio of funds. The funds need to be of a size – and have critical mass – that makes them commercially viable, building upon the existing skills of established fund managers who possess specialist knowledge. Therefore, the required minimum fund size is usually DKK 400-500 million (EUR 54-70 million).

Investment date: December 2017

Commitment:  DKK 200m

Fund size: DKK 2,975m

Ownership share: 6.7 %

Advisory board member: Nils Johannessen

Investment strategy: Dansk Vækstkapital II invests in unlisted funds with a view to achieving a competitive and double-digit return for the combined portfolio of funds. The funds need to be of a size – and have critical mass – that makes them commercially viable, building upon the existing skills of established fund managers who possess specialist knowledge. Therefore, the required minimum fund size is usually DKK 400-500 million (EUR 54-70 million).

Investment date: April 2002

Commitment: USD 250m

Fund size: USD 1,202m

Ownership share: 20.8 %

Advisory board member: No

Investment strategy: Goldman Sachs is a fund-of-funds investing in buyout, venture capital, secondary funds and direct investments primarely in the US and Europe. The firm has several offices throughout the US, Europe and Asia.

Investment date: December 2004

Commitment: USD 150m

Fund size: USD 1,133m

Ownership share: 13.2 %

Advisory board member: No

Investment strategy: Goldman Sachs is a fund-of-funds investing in buyout, venture capital, secondary funds and direct investments primarely in the US and Europe. The firm has several offices throughout the US, Europe and Asia.

Investment date: April 2005

Commitment: USD 150m

Fund size: USD 1,470m

Ownership share: 10.2 %

Advisory board member: No

Investment strategy: Goldman Sachs is a fund-of-funds investing in buyout, venture capital, secondary funds and direct investments primarely in the US and Europe. The firm has several offices throughout the US, Europe and Asia.

Investment date: June 2007

Commitment: USD 200m

Fund size: USD 1,283m

Ownership share: 15.6 %

Advisory board member: No

Investment strategy: Goldman Sachs is a fund-of-funds investing in buyout, venture capital, secondary funds and direct investments primarely in the US and Europe. The firm has several offices throughout the US, Europe and Asia.

Investment date: July 2002

Commitment: SEK 300m

Fund size: SEK 3,000m

Ownership share: 10 %

Advisory board member:  Nils Johannessen

Investment strategy: HealthCap is a Swedish venture fund primarily investing in early- and late stage companies within the healthcare sectors: therapeutics and platform technologies. Geographical focus is on Scandianavia but also Europe and the US.

.

Investment date: December 2002

Commitment: SEK 275m

Fund size: SEK 1,193m

Ownership share: 23.1 %

Advisory board member: No

Investment strategy: IT Provider is a Stockholm-based VC fund investing in Scandinavian IT companies. The firm typically makes minority investments in early and expansion stage companies within software and communication.

Investment date: June 2000

Commitment: SEK 330m

Fund size: SEK 6,170m

Ownership share: 5.4 %

Advisory board member: No

Investment strategy: Nordic Capital invests in large and medium-sized companies, primarily in the Nordic region, and in the rest of Europe. Its industry focus is diversified, with focus on the healthcare sector. The Stockholm based firm targets operating improvements, restructurings, consolidations and strategic new orientation and also buy-and-build strategies.

Investment date: January 2003

Commitment: EUR 28m

Fund size: EUR 240m

Ownership share: 11.4 %

Advisory board member:  Nils Johannessen

Investment strategy: Nordic Mezzanine provides mezzanine financing for buyouts, growth and capital restructuring. The fund has offices in Helsinki and London and main regional focus in the Nordic area, German speaking countries and Benelux Nordic Mezzanine.

Investment date: December 2004

Commitment: EUR 15m

Fund size: EUR 1,100m

Ownership share: 12.9 %

Advisory board member: No

Investment strategy: Nordic Venture Partners is a venture fund based in Denmark. The firm invests in seed, and later stage companies taking preference to technology enabled companies in the Nordic region.

Investment date: July 2000

Commitment: DKK 24m

Ownership share: 17.3 %

Advisory board member: No

Investment strategy: NOVI invests in early stage growth oriented companies focusing on diagnose products, medical devices, software, and wireless technologies. In addition NOVI also runs a science park. The fund is based in Aalborg, DK.

Investment date: February 2000

Commitment: DKK 1,000m

Fund size: DKK 4,100m

Ownership share: 24.4 %

Advisory board member: Torben Vangstrup

Investment strategy: Saga Private Equity Partners is a fund-of-funds investing in buyout, venture capital and secondary funds in the US and Europe. The firm is based in Copenhagen.

Investment date: February 2002

Commitment: EUR 72m

Fund size: EUR 250m

Ownership share: 28.9 %

Advisory board member: Torben Vangstrup

Investment strategy: Saga Private Equity Partners is a fund-of-funds investing in buyout, venture capital and secondary funds in the US and Europe. The firm is based in Copenhagen.

Investment date: February 2002

Commitment: USD 65m

Fund size: USD 225m

Ownership share: 28.9 %

Advisory board member: Torben Vangstrup

Investment strategy: Saga Private Equity Partners is a fund-of-funds investing in buyout, venture capital and secondary funds in the US and Europe. The firm is based in Copenhagen.

Investment date: June 2006

Commitment: EUR 75m

Fund size: EUR 304m

Ownership share: 24.7 %

Advisory board member: Torben Vangstrup

Investment strategy: Saga Private Equity Partners is a fund-of-funds investing in buyout, venture capital and secondary funds in the US and Europe. The firm is based in Copenhagen.

Investment date: June 2006

Commitment: USD 92m

Fund size: USD 632m

Ownership share: 14.5 %

Advisory board member: Torben Vangstrup

Investment strategy: Saga Private Equity Partners is a fund-of-funds investing in buyout, venture capital and secondary funds in the US and Europe. The firm is based in Copenhagen.

Investment date: December 2004

Commitment: DKK 93m

Fund size: DKK 531m

Ownership share: 17.4 %

Advisory board member: Klaus Rühne

Investment strategy: Seed Capital is a Danish venture fund investing in seed and early stage companies in Denmark and Skåne. Focus is on IT, telecommunication, biotech, pharma and medico sectors.

Investment date: January 2010

Commitment: DKK 150m

Fund size: DKK 682m

Ownership share: 22 %

Advisory board member: Klaus Rühne

Investment strategy: Seed Capital is a Danish venture fund investing in seed and early stage companies in Denmark and Skåne. Focus is on IT, telecommunication, biotech, pharma and medico sectors.

Investment date: March 2016

Commitment: DKK 50m

Fund size: DKK 819m

Ownership share: 6.11 %

Advisory board member: Klaus Rühne

Investment strategy: Seed Capital is a Danish venture fund investing in seed and early stage companies in Denmark and Skåne. Focus is on IT, telecommunication, biotech, pharma and medico sectors.

Investment date: December 2004

Commitment: DKK 16m

Fund size: DKK 131m

Ownership share: 11.9 %

Advisory board member: Nils Johannessen

Investment strategy: Sunstone Biomedical is a Nordic-based early stage venture capital investor focusing on developing and expanding early-stage Life Science and Technology companies. The firm is based in Copenhagen with an office in Menlo Park.

Investment date: December 2004

Commitment: DKK 103m

Fund size: DKK 1.7bn

Ownership share: 19.3 %

Advisory board member: Nils Johannessen

Investment strategy: Sunstone Biomedical is a Nordic-based early stage venture capital investor focusing on developing and expanding early-stage Life Science and Technology companies. The firm is based in Copenhagen with an office in Menlo Park.

Investment date: July 2001

Commitment: DKK 300m

Fund size: DKK 1,691m

Ownership share: 17.8 %

Advisory board member: Nils Johannessen

Investment strategy: Sunstone Biomedical is a Nordic-based early stage venture capital investor focusing on developing and expanding early-stage Life Science and Technology companies. The firm is based in Copenhagen with an office in Menlo Park.

Investment date: July 1993

Commitment: DKK 4m

Fund size: 

Ownership share: 3.6 %

Advisory board member: No

Investment strategy: Symbion is the largest science park in Denmark. The fund invests in early stage companies focusing on innovative and high-tech projects in the fields of IT, telecommunication, biotech, pharma, and medtech.

Investment date: January 2001

Commitment: DKK 56m

Fund size: DKK 225m

Ownership share: 25 %

Advisory board member: No

Investment strategy: Symbion is the largest science park in Denmark. The fund invests in early stage companies focusing on innovative and high-tech projects in the fields of IT, telecommunication, biotech, pharma, and medtech.

Investment date: July 2016

Commitment: DKK 499m

Fund size: DKK 1,000m

Ownership share: 49.9 %

Advisory board member: No

Investment strategy: The core investment focus is within a broad definition of the TMT/ICT and Services industries primarily in small and medium-sized companies with revenue from EUR 10 million to EUR 100 million.

Investment date: January 2000

Commitment: DKK 2m

Ownership share: 2.1 %

Advisory board member: No

Investment strategy: VP Securities is a Copenhagen-based fund who provides solutions and know how to financial institutions.